Cramer’s week ahead: Don’t let the Fed’s meeting obscure investing opportunities

Cramer’s week ahead: Don’t let the Fed’s meeting obscure investing opportunities


Cramer's week ahead: Don't let the Fed's meeting obscure investing opportunities

CNBC’s Jim Cramer on Friday advised investors to keep their eyes peeled for chances to improve their portfolios next week.

“These big macro numbers and important Fed meetings are a drag – I know. They obscure the actual opportunities out there. I want you to keep your eyes open for ideas and not be blinded by the [Federal Reserve] light,” he said.

related investing news

Jim Cramer's Investing Club meeting Friday: Inflation data, Salesforce, Microsoft trouble

CNBC Investing Club

Stocks tumbled to end the week down on Friday, roiled by investors’ worries about a possible recession. Two key economic events take place next week, including the release of the November consumer price index report and the Federal Reserve’s December meeting.

Wall Street expects the Fed to raise interest rates by 50 basis points.

“We need to see a cooler consumer price index, with the Fed only raising interest rates by 50 basis points and then saying they’ll take some time to assess the situation before they tighten again,” Cramer said.

He also previewed next week’s slate of earnings. All earnings and revenue estimates are courtesy of FactSet.

Monday: Coupa Software, Oracle

Coupa Software

  • Q3 2023 earnings release at 4:03 p.m. ET; conference call at 4:30 p.m. ET
  • Projected EPS: 17 cents
  • Projected revenue: $252 million

Cramer predicted that the stock will fall if the company doesn’t prioritize profitability over growth.

Oracle

  • Q2 2023 earnings release at 4 p.m. ET; conference call at 5 p.m. ET
  • Projected EPS: $1.17
  • Projected revenue: $11.95 billion

“At 16 times earnings, I just don’t see how much there is to lose,” he said.

Tuesday: Eli Lilly

  • 2023 guidance call at 9 a.m. ET

Investors who don’t already own shares of Eli Lilly should wait to buy until after the call, Cramer advised.

Wednesday: Lennar

  • Q4 2022 earnings release at 4:30 p.m. ET; conference call on Thursday at 11 a.m. ET
  • Projected EPS: $4.88
  • Projected revenue: $9.98 billion

He predicted that the company will likely report a “terrific” quarter, which would be bad news for the Fed’s battle against inflation.

Thursday: Adobe

  • Q4 2022 earnings release at 4:05 p.m. ET; conference call at 5 p.m. ET
  • Projected EPS: $3.50
  • Projected revenue: $4.53 billion

Cramer said that it’s too soon to buy shares of Adobe.

Friday: Darden Restaurants, Accenture

Darden Restaurants

  • Q2 2023 earnings release at 7 a.m. ET; conference call at 8:30 a.m. ET
  • Projected EPS: $1.43
  • Projected revenue: $2.43 billion

The company will likely report a solid quarter, he predicted.

Accenture

  • Q1 2023 earnings release at 6:45 a.m. ET; conference call at 8 a.m. ET
  • Projected EPS: $2.92
  • Projected revenue: $15.58 billion

“If you think, as I do, that companies will cut back on digitization going forward in order to attempt to save money, you might want to avoid Accenture,” Cramer said.

Disclaimer: Cramer’s Charitable Trust owns shares of Eli Lilly.

Cramer's game plan for the trading week of Dec. 12

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

How Build-A-Bear went from a penny stock to a retail winner
Business

How Build-A-Bear went from a penny stock to a retail winner

Build-A-Bear Workshop wasn’t always a retail winner. The toy store, known for its interactive experience of building and accessorizing stuffed animals, has gone through a significant turnaround since CEO Sharon Price John took the helm of the company over a decade ago. “When I first came in 2013, that assessment of the brand was strong,” […]

Read More
Inside the dealmaking that pushed Trump to reclassify pot, expand access
Business

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump’s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president’s inner circle, industry […]

Read More
Shoppers are focusing on quality, not deals, in the final days before Christmas
Business

Shoppers are focusing on quality, not deals, in the final days before Christmas

While discounts drive purchasing in the early days of the holiday shopping season, consumers are shifting into more thoughtful, quality gifts in the back half of the season as total spending growth slows. U.S. consumers had spent $187.3 billion so far online between Nov. 1 and Dec. 12, up 6.1% from the same stretch last […]

Read More